REGENXBIO
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGEDWord Mark
Never miss important updates for REGENXBIO
Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach
Key Information
Ownership
RI
Address
9804 Medical Center Drive
Rockville, MD 20850
Critical Dates
First Use Date
Sep 1, 2014
Filing Date
Sep 17, 2014
Registration Date
Aug 9, 2016
Mark Descriptions
Services
Class 42
Custom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy, and therapeutic compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic...
Mark Elements
Text Mark
REGENXBIO
Category
Service Mark
Standard Characters
No
Color Claim
No
Trademark Timeline
First Use
Filing Date
Publication Date
Registration Date
USPTO Records
No documents found for this trademark.